
Company Number
11781130
Next Accounts
Sep 2025
Shareholders
bq holding ltd
Group Structure
View All
Industry
Other human health activities
Registered Address
acre house 11/15 william road, london, NW1 3ER
Website
bioniq.comPomanda estimates the enterprise value of BIONIQ HEALTH-TECH SOLUTIONS LIMITED at £607.6k based on a Turnover of £1.3m and 0.47x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of BIONIQ HEALTH-TECH SOLUTIONS LIMITED at £0 based on an EBITDA of £-1.1m and a 3.55x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of BIONIQ HEALTH-TECH SOLUTIONS LIMITED at £327.5k based on Net Assets of £146.7k and 2.23x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Bioniq Health-tech Solutions Limited is a live company located in london, NW1 3ER with a Companies House number of 11781130. It operates in the other human health activities sector, SIC Code 86900. Founded in January 2019, it's largest shareholder is bq holding ltd with a 100% stake. Bioniq Health-tech Solutions Limited is a young, small sized company, Pomanda has estimated its turnover at £1.3m with declining growth in recent years.
Pomanda's financial health check has awarded Bioniq Health-Tech Solutions Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 6 areas for improvement. Company Health Check FAQs
3 Strong
3 Regular
6 Weak
Size
annual sales of £1.3m, make it larger than the average company (£799.9k)
- Bioniq Health-tech Solutions Limited
£799.9k - Industry AVG
Growth
3 year (CAGR) sales growth of -10%, show it is growing at a slower rate (6.5%)
- Bioniq Health-tech Solutions Limited
6.5% - Industry AVG
Production
with a gross margin of 36.3%, this company has a comparable cost of product (36.3%)
- Bioniq Health-tech Solutions Limited
36.3% - Industry AVG
Profitability
an operating margin of -82.3% make it less profitable than the average company (5.5%)
- Bioniq Health-tech Solutions Limited
5.5% - Industry AVG
Employees
with 14 employees, this is below the industry average (19)
14 - Bioniq Health-tech Solutions Limited
19 - Industry AVG
Pay Structure
on an average salary of £27k, the company has an equivalent pay structure (£27k)
- Bioniq Health-tech Solutions Limited
£27k - Industry AVG
Efficiency
resulting in sales per employee of £92.8k, this is more efficient (£51.5k)
- Bioniq Health-tech Solutions Limited
£51.5k - Industry AVG
Debtor Days
it gets paid by customers after 20 days, this is near the average (22 days)
- Bioniq Health-tech Solutions Limited
22 days - Industry AVG
Creditor Days
its suppliers are paid after 73 days, this is slower than average (17 days)
- Bioniq Health-tech Solutions Limited
17 days - Industry AVG
Stock Days
it holds stock equivalent to 159 days, this is more than average (16 days)
- Bioniq Health-tech Solutions Limited
16 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 28 weeks, this is less cash available to meet short term requirements (101 weeks)
28 weeks - Bioniq Health-tech Solutions Limited
101 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 97.6%, this is a higher level of debt than the average (27.9%)
97.6% - Bioniq Health-tech Solutions Limited
27.9% - Industry AVG
Bioniq Health-Tech Solutions Limited's latest turnover from December 2023 is estimated at £1.3 million and the company has net assets of £146.7 thousand. According to their latest financial statements, Bioniq Health-Tech Solutions Limited has 14 employees and maintains cash reserves of £3.3 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Jan 2020 | |
---|---|---|---|---|---|
Turnover | |||||
Other Income Or Grants | |||||
Cost Of Sales | |||||
Gross Profit | |||||
Admin Expenses | |||||
Operating Profit | |||||
Interest Payable | |||||
Interest Receivable | |||||
Pre-Tax Profit | |||||
Tax | |||||
Profit After Tax | |||||
Dividends Paid | |||||
Retained Profit | |||||
Employee Costs | |||||
Number Of Employees | 14 | 12 | 12 | 10 | 9 |
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Jan 2020 | |
---|---|---|---|---|---|
Tangible Assets | 33,335 | 43,543 | 47,814 | 12,293 | 16,422 |
Intangible Assets | 1,833 | 7,333 | 12,375 | ||
Investments & Other | |||||
Debtors (Due After 1 year) | |||||
Total Fixed Assets | 33,335 | 43,543 | 49,647 | 19,626 | 28,797 |
Stock & work in progress | 361,683 | 138,767 | 105,819 | 93,319 | 38,620 |
Trade Debtors | 72,951 | 58,244 | 3,075 | 232,589 | 5,725 |
Group Debtors | 275,069 | 1,010,203 | 1,385,827 | 192,258 | 172,993 |
Misc Debtors | 2,041,535 | 92,696 | 245,233 | 78,165 | 52,228 |
Cash | 3,254,491 | 60,225 | 760,526 | 92,474 | 145,305 |
misc current assets | |||||
total current assets | 6,005,729 | 1,360,135 | 2,500,480 | 688,805 | 414,871 |
total assets | 6,039,064 | 1,403,678 | 2,550,127 | 708,431 | 443,668 |
Bank overdraft | |||||
Bank loan | 5,715 | 5,574 | 5,530 | 3,333 | |
Trade Creditors | 165,512 | 173,571 | 292,675 | 107,913 | 64,929 |
Group/Directors Accounts | 2,294,225 | 4,050,138 | 2,062,747 | ||
other short term finances | 143,157 | 119,222 | 119,222 | ||
hp & lease commitments | |||||
other current liabilities | 3,252,202 | 45,688 | 246,115 | 314,030 | 962,890 |
total current liabilities | 5,860,811 | 224,833 | 4,713,680 | 2,607,245 | 1,027,819 |
loans | 31,509 | 37,164 | 42,722 | 46,667 | |
hp & lease commitments | |||||
Accruals and Deferred Income | |||||
other liabilities | |||||
provisions | |||||
total long term liabilities | 31,509 | 37,164 | 42,722 | 46,667 | |
total liabilities | 5,892,320 | 261,997 | 4,756,402 | 2,653,912 | 1,027,819 |
net assets | 146,744 | 1,141,681 | -2,206,275 | -1,945,481 | -584,151 |
total shareholders funds | 146,744 | 1,141,681 | -2,206,275 | -1,945,481 | -584,151 |
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Jan 2020 | |
---|---|---|---|---|---|
Operating Activities | |||||
Operating Profit | |||||
Depreciation | 14,173 | 13,812 | 6,220 | 3,376 | 1,832 |
Amortisation | 1,833 | 5,500 | 5,042 | 4,125 | |
Tax | |||||
Stock | 222,916 | 32,948 | 12,500 | 93,319 | 38,620 |
Debtors | 1,228,412 | -472,992 | 1,131,123 | 503,012 | 230,946 |
Creditors | -8,059 | -119,104 | 184,762 | 107,913 | 64,929 |
Accruals and Deferred Income | 3,206,514 | -200,427 | -67,915 | 314,030 | 962,890 |
Deferred Taxes & Provisions | |||||
Cash flow from operations | |||||
Investing Activities | |||||
capital expenditure | |||||
Change in Investments | |||||
cash flow from investments | |||||
Financing Activities | |||||
Bank loans | 141 | 44 | 2,197 | 3,333 | |
Group/Directors Accounts | 2,294,225 | -4,050,138 | 1,987,391 | 2,062,747 | |
Other Short Term Loans | 143,157 | -119,222 | 119,222 | ||
Long term loans | -5,655 | -5,558 | -3,945 | 46,667 | |
Hire Purchase and Lease Commitments | |||||
other long term liabilities | |||||
share issue | |||||
interest | |||||
cash flow from financing | |||||
cash and cash equivalents | |||||
cash | 3,194,266 | -700,301 | 668,052 | 92,474 | 145,305 |
overdraft | |||||
change in cash | 3,194,266 | -700,301 | 668,052 | 92,474 | 145,305 |
Perform a competitor analysis for bioniq health-tech solutions limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other small companies, companies in NW1 area or any other competitors across 12 key performance metrics.
BIONIQ HEALTH-TECH SOLUTIONS LIMITED group structure
Bioniq Health-Tech Solutions Limited has no subsidiary companies.
Bioniq Health-Tech Solutions Limited currently has 3 directors. The longest serving directors include Mr Vadim Fedotov (Oct 2019) and Mr James Hardy (Jun 2020).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Vadim Fedotov | England | 40 years | Oct 2019 | - | Director |
Mr James Hardy | United Kingdom | 39 years | Jun 2020 | - | Director |
Mr Oliver Motisi | United Kingdom | 28 years | Jan 2023 | - | Director |
P&L
December 2023turnover
1.3m
+20%
operating profit
-1.1m
0%
gross margin
36.3%
+0.32%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
146.7k
-0.87%
total assets
6m
+3.3%
cash
3.3m
+53.04%
net assets
Total assets minus all liabilities
company number
11781130
Type
Private limited with Share Capital
industry
86900 - Other human health activities
incorporation date
January 2019
age
6
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
December 2023
previous names
N/A
accountant
-
auditor
-
address
acre house 11/15 william road, london, NW1 3ER
Bank
-
Legal Advisor
-
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to bioniq health-tech solutions limited.
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for BIONIQ HEALTH-TECH SOLUTIONS LIMITED. This can take several minutes, an email will notify you when this has completed.
date | description | view/download |
---|